CNAS: Lipsa citostaticelor nu e din vina fondurilor / Sistemul riscă colapsul dacă nu se reformează decontarea medicamentelor / „Nu pentru că nu avem bani destui, dar pentru că nu îi cheltuim eficient”

The president of CNAS, Horațiu Moldovan, acknowledged supply disruptions for certain medications, including chemotherapy drugs, but attributed these issues to production and distribution chains rather than funding shortages. He emphasized the need to rethink the pricing and reimbursement system to avoid financial unsustainability. Moldovan highlighted that medication costs have risen significantly, warning that without legislative changes, Romania could face a budget crisis for medications. He also criticized the current hospital funding model, advocating for a shift towards financing based on treated cases rather than bed availability.